Injected Facial Aesthetic Product Market Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The global injected facial aesthetics product market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Injected facial aesthetics refers to non-surgical treatments for the face that have rejuvenating or anti-aging properties. Growing trend of paying high attention over physical look among old age people is a key motivator for this industry. Therefore, the rise in the geriatric population is one of the factors driving the growth of global injected facial aesthetics products market. For instance, according to the data published by World Health Organization in 2021, the share of the population aged 60 years is anticipated to increase from 1 billion in 2020 to 1.4 billion and by 2050 the world’s population of people aged 60 and older is anticipated to double to 2.1 billion. Moreover, the number of persons aged 80 years and older are anticipated to triple between 2020 to 2050 to reach 426 million. Thus, the rise in the geriatric population is anticipated to drive the demand for facial aesthetics products during the forecast period .

Looking towards the demand for injected facial aesthetics products, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2021, Galderma Laboratories P.l had announced the launch of a new label for Sculptra (Injectable –Poly-lactic acid (PLLA)), an injectable treatment to smooth facial wrinkles such as smile lines. The new label approved by the USFDA includes higher dilution, new injection techniques, and the optional addition of lidocaine. The new label approval is based on the data from physiochemical studies, evaluating the safety and efficacy of two different dilutions of Sculptra. According to the company, the results demonstrated that 9ml including lidocaine was tolerated and caused less pain, whereas 5ml had reduced the severity of the nasolabial fold (NLF).

Further, in May 2020, Galderma Laboratories had received the USFDA approval for Restylane Kysse, a hyaluronic acid filler indicated to add fullness to the lips and assist smooth the face wrinkles. According to the company, a lower amount of Restylane Kysse (1.82ml) was needed to show an improvement in the lip fullness as compared to 2.24 ml in the phase 3 trials. Moreover, as per Dr. Melaine Palm(clinical investigator), the Restylane was shown to be safe and well-tolerated. Thus, such launches are anticipated to drive the global injected facial aesthetics products market during the forecast period (2022-2028).

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Abbvie Inc (Allergan Plc), Sinclair Pharma Plc, and Merz Pharma among others

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Injected Facial Aesthetic Product Market Report by Segment

By Type

• Dermal Fillers (Hyaluronic acid, Fat Injection, Polylactic acid, and others),
• Wrinkle Relaxers

By Application

• Facial Line Correction
• Lip Augmentation
• Face Lift
• Acne Scar Treatment
• Lipoatrophy Treatment
• Others